Cosciens Biopharma Files Routine 6-K Report
Ticker: CSCIF · Form: 6-K · Filed: May 27, 2025 · CIK: 1113423
Sentiment: neutral
Topics: reporting, compliance, foreign-private-issuer
TL;DR
Cosciens Biopharma filed a 6-K, just a routine update, no big news.
AI Summary
Cosciens Biopharma Inc. filed a Form 6-K on May 27, 2025. The company, formerly known as Aeterna Zentaris Inc. and Aeterna Laboratories Inc., is a foreign private issuer. The filing does not contain specific financial figures or operational updates but serves as a routine report.
Why It Matters
This filing indicates ongoing compliance and reporting by Cosciens Biopharma Inc. as a publicly traded entity, providing transparency to investors.
Risk Assessment
Risk Level: low — This filing is a standard procedural report and does not contain new material information that would inherently increase risk.
Key Players & Entities
- COSCIENS Biopharma Inc. (company) — Filer
- Aeterna Zentaris Inc. (company) — Former company name
- AETERNA LABORATORIES INC (company) — Former company name
- Norton Rose Fulbright Canada, LLP (company) — Legal counsel/address provider
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer has made or is about to make public in its home country, has filed or is about to file with a stock exchange, or has distributed or is about to distribute to its security holders.
When was Cosciens Biopharma Inc. formerly known as Aeterna Zentaris Inc.?
The company was formerly known as Aeterna Zentaris Inc. prior to a name change on June 17, 2004.
What is the Standard Industrial Classification (SIC) code for Cosciens Biopharma Inc.?
The SIC code for Cosciens Biopharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where is the principal executive office of Cosciens Biopharma Inc. located?
The principal executive office is located at c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7.
Does Cosciens Biopharma Inc. file annual reports under Form 20-F or Form 40-F?
Cosciens Biopharma Inc. files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 27, 2025 regarding COSCIENS Biopharma Inc. (CSCIF).